Gelatin–thrombin-based Hemostatic Sealant for Intraoperative Bleeding in Vascular Surgery
暂无分享,去创建一个
L. Messina | F. Weaver | D. Hood | B. Badduke | M. Zatina
[1] Howard S. An,et al. A Multicenter, Prospective, Randomized Trial Evaluating a New Hemostatic Agent for Spinal Surgery , 2001, Spine.
[2] M. Oz,et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery , 2000 .
[3] D. Gillespie,et al. Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial. , 1999, Journal of vascular surgery.
[4] J. Zwischenberger,et al. Comparison of two topical collagen-based hemostatic sponges during cardiothoracic procedures. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[5] R. Christie,et al. Postoperative bleeding induced by topical bovine thrombin: report of two cases. , 1997, Surgery.
[6] M. Tarantino,et al. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin. , 1997, Journal of pediatric hematology/oncology.
[7] J. Weisel,et al. Simultaneous Occurrence of Human Antibodies Directed against Fibrinogen, Thrombin, and Factor V Following Exposure to Bovine Thrombin: Effects on Blood Coagulation, Protein C Activation and Platelet Function , 1997, Thrombosis and Haemostasis.
[8] N. M. Edwards,et al. Immunologic Assessment of Patients Treated with Bovine Fibrin as a Hemostatic Agent , 1996, Thrombosis and Haemostasis.
[9] W. Wagner,et al. Comparative in vitro analysis of topical hemostatic agents. , 1996, The Journal of surgical research.
[10] R. Pierce,et al. Brief report: fatal hemorrhage in a patient with an acquired inhibitor of human thrombin. , 1995, The New England journal of medicine.
[11] D. Cosgrove,et al. Randomized Clinical Trial of Fibrin Sealant in Cardiac Surgery Patients Undergoing Resternotomy or Reoperation: A Multicenter Study , 1995 .
[12] S. Israels,et al. Development of Antibodies to Bovine and Human Factor V in Two Children After Exposure to Topical Bovine Thrombin , 1994, American Journal Of Pediatric Hematology/Oncology.
[13] T. Ortel,et al. Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis , 1994, American journal of hematology.
[14] W. Muntean,et al. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old child , 1994, Acta paediatrica.
[15] A. Tobler,et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V , 1993, British journal of haematology.
[16] J. Amiral,et al. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. , 1993, Journal of Thoracic and Cardiovascular Surgery.
[17] R. E. Clark,et al. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency. , 1993, The Journal of thoracic and cardiovascular surgery.
[18] S. Rapaport,et al. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. , 1992, American journal of clinical pathology.
[19] J. Zehnder,et al. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. , 1990, Blood.
[20] D. Cosgrove,et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. , 1989, The Journal of thoracic and cardiovascular surgery.